Drug Shortage Report for GD-AZITHROMYCIN

Last updated on 2017-05-06 History
Report ID 8733
Drug Identification Number 02274574
Brand name GD-AZITHROMYCIN
Common or Proper name GD-AZITHROMYCIN
Company Name GENMED A DIVISION OF PFIZER CANADA ULC
Market Status CANCELLED POST MARKET
Active Ingredient(s) AZITHROMYCIN
Strength(s) 200MG
Dosage form(s) POWDER FOR SUSPENSION
Route of administration ORAL
Packaging sizes (GTIN)

Click here to see a list of all reports for this drug.

(See additional packaging sizes)
Additional packaging sizes 600mg/15mL
ATC code J01FA
ATC description MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2017-04-21
Estimated end date 2017-05-16
Actual end date 2017-05-05
Shortage status Resolved
Updated date 2017-05-06
Company comments Resolved May 5, 2017
Health Canada comments
Tier 3 Status No
Contact Address 17300 TRANS CANADA HIGHWAY
KIRKLAND, QUEBEC
CANADA H9J 2M5
Company contact information Customer Service / service à la clientèle : 1-800-387-4974 Email / courriel: [email protected]

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v7 2017-05-06 English Compare
v6 2017-05-05 French Compare
v5 2017-05-05 English Compare
v4 2017-05-02 French Compare
v3 2017-05-02 English Compare
v2 2017-05-02 French Compare
v1 2017-05-02 English Compare

Showing 1 to 7 of 7